Rochester Institute of Technology

RIT Scholar Works
Theses
8-1-2008

Evaluation of a numerical thrombosis model for a high shear
rotating flow
Carlos Cheek

Follow this and additional works at: https://scholarworks.rit.edu/theses

Recommended Citation
Cheek, Carlos, "Evaluation of a numerical thrombosis model for a high shear rotating flow" (2008). Thesis.
Rochester Institute of Technology. Accessed from

This Thesis is brought to you for free and open access by RIT Scholar Works. It has been accepted for inclusion in
Theses by an authorized administrator of RIT Scholar Works. For more information, please contact
ritscholarworks@rit.edu.

EVALUATION OF A NUMERICAL THROMBOSIS MODEL
FOR A HIGH SHEAR ROTATING FLOW
By

Carlos Cheek
A thesis submitted in partial fulfillment of the Requirement for

Master of Science
in
Mechanical Engineering

Approved by:
Dr. Steven Day
Department of Mechanical Engineering

_____________________________________
(Thesis Advisor)

Dr. Kathleen Lamkin - Kennard
Department of Mechanical Engineering

_____________________________________

Dr. Risa Robinson
Department of Mechanical Engineering

_____________________________________

Dr. Wayne Walter
Department of Mechanical Engineering

_____________________________________
(Dept Representative)

Dr. Richard Doolittle
Department of Life Sciences

_____________________________________

i

ii

iii

iv

Abstract
Blood clotting, or thrombosis, is an interesting biological application for computational fluid
dynamics. Existing numerical thrombosis models have previously been shown to be effective for
low shear rates and simple geometries. For these models to be used in biomedical applications
such as the design of rotary blood pumps, however, they must first be experimentally validated
for high shear rates and complex geometries. In this study, we test the ability of a numerical
thrombosis model to predict thrombosis related phenomena in a high shear flow by creating a
geometry similar to that of a rotary blood pump. We have applied an existing numerical
thrombosis model to an annular gap between rotating concentric cylinders, a geometry that is
closely related to rotary blood pumps. Additionally, we created a physical model of the same
geometry and exposed blood to a range of shear rates in both the empirical and numerical model.
The empirical and numerical results are compared in order to evaluate the ability of the
numerical model to predict thrombosis in similar geometries, such as high shear blood handling
pumps.
Fluent was used to solve the coupled convective-diffusion equations along with user defined
equations that include production and consumption of 7 species critical to thrombosis. These
equations, along with equations of fluid motion, were solved iteratively within the Fluent solver.
All reaction constants were from previously published work. At each of the shear rates and
exposure times tested, the numerical model calculated platelet deposition, platelet-platelet
aggregation and the two-dimensional distribution of three primary agonists (ADP, thromboxane
and thrombin) in addition to the standard fluid variables (velocity, pressure, shear rate, etc.)
A physical model was designed and constructed to control the shear rate to which blood is
exposed. An annular gap of 360µm was chosen in order to induce a shear rate of up to 10,000 s-1
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while maintaining laminar flow. In a series of experiments, fresh, heparinized, bovine blood was
exposed to a constant shear rate ranging from 1,000 to 10,000 s-1 for 120 seconds. Prothrombin
time (PT) and activated partial thromboplastin time (APTT) of the blood was then measured for
each stress level.
While the observed changes in thromboembolitic potential (as measured by PT and APTT) of
the whole blood test samples qualitatively correspond to platelet activation and agonist
concentration predicted by the numerical model, further work is needed to quantitatively verify
the numerical model. Thrombosis models based on coupled convective-diffusion equations show
promise, but need further refinement and validation before they can be trusted to authoritatively
predict thromboembolitic potential.
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1 Introduction
Thrombosis, the formation of blood clots, remains one of the most significant challenges in
the design of blood contacting medical devices such as implantable blood pumps, hemodialysis,
and blood oxygenators [Gartner, 2000]. An attached clot can grow until it obstructs the natural
flow and a detached or suspended embolus may travel through the blood stream until it
eventually obstructs a vessel. The design methodology of blood handling devices has progressed
remarkably in the past years, largely because of the use of finite element analysis and
computational fluid dynamics [Burgreen, 1996]. Nonetheless, the prediction of thrombosis in
devices is unsatisfactory because there is not a validated model that can be used for the
predictions.
Thrombosis is principally due to three factors: platelet transport, coagulation cascade, and
haemodynamics. While considerable research has gone into studying the underlying mechanisms
of thrombosis [Basmadjian, 1997; Chang, 1988; Fogelson. 1984] these models are generally not
quantitative enough to decidedly predict the occurrence of thrombosis. While many studies of
thrombosis focus on one of the three mechanisms in order to gain insight into specific area of the
larger problem, the design process needs a single comprehensive model that includes effects of
platelets, surface chemistry and haemodynamics. One of the more promising models was
developed by Sorensen [1999] and included platelets and 5 agonists, chemical species that are
part of the biochemical cascade of thrombogenesis. The model accounts for the agonist induced
activation of platelets, enhanced species diffusion, attachment of platelets to the solid surfaces,
and convective and diffusive transport of platelets by the flow. Goodman [2005] implemented
the Sorensen model using Fluent, a commercially available CFD package and determined
reaction rate constants of platelet deposition and embolization from his own experiments.
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To date, this coagulation model has been applied to relatively simple geometries and flow
regimes such as an abrupt cylindrical contraction or expansion [Goodman, 2005], or
physiological conditions of shear rate and material [Sorensen, 1999]. The model was compared
to empirical data and was shown to be effective for these cases [Goodman, 2005; Sorensen,
1999]. However, the experimental data have been case dependent and more research is needed
to determine how robust this numerical model is. Unlike physiological flows, the flow within
blood prostheses is often characterized by high shear rates, bio-reactive materials, and
turbulence. While the implementation of the model in Fluent make it feasible to apply the model
to complex geometries such as mechanical blood pumps, the validity of the model in these
applications is questionable because of both high shear rates and non-biological materials.
The objective of this study is to test the validity of applying these numerical models to a
geometry that more closely resembles rotary blood pumps. Specifically, we use the annular flow
between rotating cylinders to create a shear flow with controllable shear rate. We have
implemented the thrombosis model on this geometry and conducted numerical experiments by
varying the shear rate. Additionally, we have designed and constructed a mechanical apparatus to
expose whole blood to the same conditions. We compare the numerical and empirical results in
an effort to determine under what, if any, conditions the model is valid.

2

2 Background

2.1 Biological Contributors to Thrombosis
2.1.1 Platelet
The platelet is a non-nucleated blood fragment of irregular shape. It will typically have a
diameter of 2 to 4 microns. In healthy, whole blood they number 250,000 platelets/mm3, but
make up less than 1% of the total blood volume. The main function of platelets is to maintain
hemostasis by forming a thrombus or clot. Platelets exist in two states: activated and unactivated.
When visually inspected, unactivated platelets have a variable disc shape. When a platelet
activates, it forms pseudopods. The pseudopods stretch out like tentacles and give the platelet an
irregular star shape as seen in Figure 1. When a platelet activates, it also releases chemicals such
as thromboxane A2 and adenosine diphosphate which further encourage clot formation. Platelet
activation can occur due to many factors or a combination of factors including contact with subendothelial cells, high concentrations of agonists or exposure to high shear rates. Platelets appear
purple when viewed under a microscope when a Romanowsky stain is used as seen in Figure 2.
[Stiene-Martin, 1998; McKenzie, 1996]
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Figure 1: Image of titanium surface with attached unactivated platelets (top) and attached
activated platelets (bottom). Note the change in morphology of the activated platelets. From
Jones, 2000 pg 416.
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Figure 2: Attached platelets on a polycarbonate surface at 10x magnification. The platelets
are a purple / pink color from the Romanowsky stain.

2.1.2 Coagulation Cascade
The coagulation cascade is the enzymatic process that ends with fibrin formation and
ultimately leads to clot formation. The cascade can be activated by contact with either tissue
factor (extrinsic) or a negatively charged surface (intrinsic). The extrinsic pathway begins
with tissue thromboplastin (FVII) and the intrinsic pathway begins with Hageman factor (FXII).
Both pathways lead to the common pathway. In the common pathway, prothrombin (FII) in the
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presence of calcium is converted to thrombin (FIIa). Thrombin with calcium will convert
fibrinogen that is present in whole blood into a stable fibrin clot.
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Figure 3: Coagulation cascade from Stiene-Martin, Clinical Hematology pg. 614
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2.1.3 Haemostasis
Haemostasis is the control of bleeding when a blood vessel is damaged. When blood flows
past damaged, exposed sub-endothelial tissue, platelets immediately begin to adhere to the
exposed collagen. In the presence of ADP, platelets will quickly clump to one another as well as

Figure 4: Illustration of the hemostatic process showing platelet attachment, activation and
fibrin clot formation. From McKenzie, Textbook of Hematology, pg 490.
to the damaged tissue. Platelets can also adhere to the damaged tissue with the electrostatic force
between the positively charged calcium ions and the negatively charged platelets and damaged
tissue. The platelets then release proteins that, in the presence of ATP and glucose, pull together
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the fibrin clot. This process is called clot retraction. [Platt, 1979] Error! Reference source not
found. illustrates the clot formation process.

2.2 Experimental Thrombosis Research
There are many different areas of thrombosis research. Many of them are clinical or
diseased state studies, and have little direct impact on the current model. The current research is
focused on platelet transport, platelet attachment to biomaterial surfaces and platelet activation.
More specifically, the the study focuses on the role that a shear fluid plays in these areas. The
following sections outline experiments studying the effects of shear on platelets and platelet
functions.

2.2.1 Effect of Shear on Platelet Deposition
Platelet deposition on a biomaterial surface has been the focus of much research;
however, the influence of shear rate on platelet deposition is still not fully characterized. A
comparison between Neumann et al. [1980] static exposure and Leonard et al. [1967] flowing
exposure of fluorinated ethylene propylene (FEP) shows that flowing blood will deposit more
platelets in the same amount of time. Grabowski et al. [1972] exposed glass to whole canine
blood at shear rates of 20, 40, and 80 sec-1. Grabowski et al. showed that a material has a
saturation point where that material has the maximum number of platelets deposited on the
surface. The authors also demonstrated that increasing shear rate increased the rate that a
material reached its saturation point. There have been several experiments demonstrating
increasing platelet deposition with increasing shear rate; [Grabowski, 1972; Strong, 1987;
Turitto, 1975; Hubbell, 1986; Alevriadou, 1993; Schaub, 1999; Jones, 2000] however, the
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highest shear rate studied was 3000s-1. [Alevriadou, 1993] These experiments are summarized in
Table 1.

Table 1: Summary of platelet deposition experiments
Shear Rates (s- Exposure
1)
Time (sec)

Highest
Recorded
Depostion

Reference

Fluid

Material

Schaub, 1999

Heparinized
human
whole blood

Ti, LTIC, DLC,
PCD, Dacron,
HEM, ePTFE,
dePTFE

50, 250

300

1.70E+10

plt m-2

Alevriadou, 1993

Heparinized
human
whole blood

Collagen
coated glass

100, 800,
1500, 5000

60

1.90E+11

plt m-2

Sodium
citrated
Mounted
6.6, 52, 208,
whole rabbit subendothelium
247, 832
blood

180

55

% surface
coverage

Turitto, 1975

Heparinized
Grabowski, 1972 canine whole
blood

Hubbell, 1986

Hepranized
whole
human blood

Glass

20, 40, 80

2700

6.60E+10

plt m-2

Collagen
coated glass

100, 500, 1500

120

6.00E+11

plt m-2

2.2.2 Effects of Shear on Platelet Activation and Aggregation
Platelet activation plays a large role in thrombosis. There have been several studies
investigating how exposure to a shear field influences platelet activation. Anderson et al.
[Anderson, 1978] used a concentric cylinder viscometer to expose platelet rich plasma (PRP) to a
controlled shear field. The cylinders were designed to be biologically inert to minimize the
platelet-surface interaction. The authors then measured platelet aggregation and lysis. At a shear
of 5000 s-1, there was a 60% decrease in platelet count due to platelet aggregation in the bulk
flow. The threshold for platelet lysis for a 5 minute exposure was 5000 s-1 and, for a 30 second
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exposure, it was 20,000 s-1. Hellums has a vast body of research in the field of thrombosis and
provides a review in Hellums, 1993. Equation 12 governing shear induced platelet activation was
developed from the data provided in this review.

2.2.3 Effects of Shear on Platelet Diffusivity
Many experiments have been conducted to quantify the enhanced diffusion of platelets in
whole blood. The earliest experiments used platelet rich and platelet poor blood to create a
washout curve. Platelets were counted using an automatic platelet counter. The highest shear rate
tested was 440 s-1 . These experiments generated a power-law relationship between shear rate and
effective diffusivity; however the experiments were not sensitive enough to accurately determine
the relationship between diffusivity and shear rate [Leonard, 1972; Turitto, 1975; Grabowsk,
1972i; Strong, 1987]. Currently, there are two popular methods of characterizing the enhanced
diffusion of platelets: Keller [1971] or Zydney and Colton [1982]. Both methods use a linear
relationship between shear rate and enhanced diffusivity, however each uses a different method
of determining the diffusion enhancement coefficient (the constant that is multiplied by shear
rate). To determine the diffusion enhancement coefficient, Keller derives a relationship to the
diameter of a red blood cell, while Zydney and Colton determine it empirically. Sorensen [1999]
used the method proposed by Keller, while Goodman [2005] and Wootton [2001] used the
method proposed by Zydney and Colton. Equation 13 is the equation for the enhanced platelet
diffusion coefficient used by Goodman and the current research. 5000 s-1 is the highest shear rate
that the enhanced diffusion of platelets has been experimentally validated for [Keller 1986].
Wootton and Goodman both used the method of describing the enhanced diffusion of
platelets proposed by Zydney and Colton, but each used a different diffusion enhancement
coefficient. Wootton only considered the experimental results of Zydney and Colton, while
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Goodman calculated the diffusion enhancement coefficient using experimental results from 4
separate researchers [Hubbel 1986; Turitto 1972; Aarts 1986; Zydney 1982]. Wooton used a
diffusion enhancement coefficient of 7E-9, while Goodman calculated it to be 6E-10. The
change in the enhanced diffusion of platelets due to these values is shown in Figure 5.

Enhaced Platelet Diffusion cm 2s-1

1.00E-04

1.00E-05

1.00E-06

1.00E-07

1.00E-08
Goodman

1.00E-09
0

2000

4000

6000

8000

Wootton
10000

12000

Shear Rate s-1

Figure 5: The difference in the enhanced platelet diffusion of Goodman and Wootton.
Goodman used a diffusion enhancement coefficient of 6E-10 and Wootton used 7E-9.

2.2.4 Platelet Embolization
Goodman et al. provide the only quantitative measure of platelet embolization due to shear.
Goodman conducted a series of experiments in which he exposed polyethylene (PE) tubing to
whole blood at a steady flow rate for 3 min. The authors then rinsed the tubing with a saline
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solution at varying shear rates from 0 to 6000 s-1. Goodman et al. then took a measure of percent
platelets remaining. The authors fit the experimental data with a curve shown in Equation 1

Femb = e −0.0095γ
where

Femb is

the percent platelets remaining and

Equation 1

γ is the shear rate.

Equation 1 is used to

calculate Boundary Source Term #1 in Table 3.

2.3 Analytical and Computational Models of Thrombosis
2.3.1 Haemodynamic Models
Haemodynamic models use information from the flow field such as shear rate and
reattachment points to estimate how and where thrombosis or other particle mediated deposits
will form [Nazemi, 1989; Kleinstreuer, 1991; Lee, 1995]. Fry reported findings of atherosclerotic
plaque formation in vascular bifurcations and proposed a critical shear stress at which plaque
begins to form. [Fry 1969, 1973] Fry defined the critical shear stress to be 0.5 of the shear stress
for Poiseuille flow in a pipe of the same diameter. Nazemi et al. applied Fry’s method to an
aortic bifurcation. [Nazemi, 1989] They solved the conservation of mass and momentum
equations using the Galerkin finite element method. The wall shear stress was then calculated.
The locations with wall shear stress less than the critical shear stress were identified and a thin
sinusoidal mass layer was placed onto the wall. The mesh was redefined to incorporate the new
sinusoidal wall and the governing fluid equations were resolved. This iterative process developed
a solution for plaque formation and growth on the vascular wall. The size and location of the
plaque formation coincided with clinical observations of the aortic bifurcation. This model has
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only been applied to bifurcating geometries. While this model was shown to be effective at
predicting plaque formation in a bifurcation, this model is highly influenced by the previous
knowledge of plaque formation in this particular geometry. The applicability of this model to
more complex geometries is questionable mainly do to the difficulty of determining a critical
shear stress were Poiseuille flow is not applicable (i.e. blood pump).

2.3.2 Cascade Models
The coagulation cascade has total of 13 inactive factors and another 6 active factors.
Hockin et al. [2002] developed a strict stoichiometric model that contained all the coagulation
factors. This model contained 27 chemical expressions to stoichiometrically describe the
coagulation cascade. This model provided insight into the limiting factors of the cascade.
However, the rate constants and results only apply when phospholipid concentrations are
saturated. The work of Basmadjian et al. [1997] provided results that are much more applicable
to biomedical applications. First, they took into account mass transport, addressing the fact that
the blood is flowing over a surface. Second, they developed solutions for low, intermediate and
high flow. Next, the authors investigated the intrinsic and extrinsic paths separately. Finally, a
time dependent solution was generated for thrombin concentration. This solution was sensitive
enough to capture the positive feedback loop created by the coagulation factors. This model,
while powerful, was still relatively simple and could potentially be implemented into CFD in its
entirety.

2.3.3 Platelet Adhesion Models
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One of the first mathematical models of platelet mediated thrombosis came from a group
of researchers out of Columbia University [Grabowski, 1972; Leonard, 1972; Turitto, 1975].
This research group used the coupled convection-diffusion equation (Equation 5) to model
platelet transport in whole blood flowing through a cylinder. They non-dimensionalized the
equation and developed an asymptotic solution. This research group did extensive work
developing the enhanced diffusivity of platelets in whole blood, the adhesion rate constant for
platelets on biomaterials, and began to look at how the biomaterial surface affects platelet
adhesion. These researchers performed a strict and thorough analytical solution to the governing
differential equations; however, some limiting assumptions had to be made to render these
equations analytically solvable and these assumptions limit the efficacy of the solution. The
largest of these assumptions include a time independent solution and diffusion-limited platelet
adhesion. It was later shown that a time dependent solution is necessary to capture the positive
feedback loop of platelet adhesion [Sorensen, 1999], and that platelet adhesion in a non-creeping
flow cannot be considered diffusion limited [Strong, 1987]. This model also did not include
any other species or factors of the coagulation cascade. Given the assumptions made and
the relative simplicity of the model, this model determined the diffusion enhancement coefficient
with 95% confidence and compared well with experimental results of platelet surface coverage
on glass.
Research from the University of Utah lead by Aaron Fogelson took advantage of new
technology to develop a finite element scheme to describe the phenomena of thrombosis. In
Fogelson's early work [Fogelson, 1984], he did rigorous development of the numerical methods
required to solve the governing equations. This publication was the foundation for numerical
solutions to not only thrombosis models, but any simulation using the coupled convection-
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diffusion equation. Fogelson continued with a similar model to Grabowski et. al. but made many
improvements. This improved model could differentiate between activated and unactivated
platelets where activated platelets were more likely to attach to the biomaterial surface and other
platelets. Fogelson also added the species ADP to his model. ADP was released when a platelet
was activated and platelets would activate when a threshold concentration of ADP was reached.
Platelets were also modeled with a radius and not as discrete points, so when platelets deposit on
the surface or aggregate together, the flow field is re-solved around them. Fogelson also
developed a complex scheme to describe the connection between aggregated platelets. In this
scheme, the link between platelets could stretch and flex from the forces of the flow field. While
this model contained many novel improvements, it also contained some shortcomings. Fogelson
applies this model to a narrow blood vessel that has a Reynolds number less than 0.1, and he
therefore neglects inertial effects. Due to this simplifying assumption and low Reynolds number,
he now only has to solve the Stoke's equation of fluid motion. This flow field also has a low,
physiological shear rate, so he can neglect the effects of shear (activation, aggregation and
enhanced diffusion) on platelets. While this makes his solution simpler, it renders his model
useless for anything besides a creeping flow. Later, Fogelson went on to develop different
versions of thrombosis models including an in-depth study of the platelet-platelet link [Fogelson,
1992] and a model purely of the coagulation cascade [Fogelson, 2003]. While Fogelson has
made tremendous contributions to the field of thrombosis modeling, currently there is no
experimental validation for any of Fogelson's models.
The research group from Rice University developed a model for thrombosis that included
more of the platelet released agonists [Hubbell, 1986; Folie, 1989]. This model specifically
looked at the effects of an attached thrombus on the flow field. They used the convection-
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diffusion equation to calculate the concentrations of ADP, TxA2, and thrombin in the flow field
around the attached thrombus. This group also used the commercial computational fluid
dynamics (CFD) program FIDAP to solve the conservation of mass and momentum equations as
well as the convection-diffusion equations. [Folie, 1989]
Sorensen et al. [1999] developed a fairly comprehensive model of thrombosis. This
computational simulation was able to generate a time dependent solution that was able to model
the synergistic effect of platelet attachment and agonist release. This model also included a
surface availability function to simulate the tendency for platelets to initially adhere as a
monolayer [Grabowski, 1972]. The Sorensen et al. model compared well to experimental results
of parallel plate flow for shear rates of 100 and 500 s-1 but did not compare well for a shear rate
of 1500 s-1. Goodman et al. [2005] added to this model an embolization term that allows adhered
platelets to embolize and return to the bulk flow after sufficient exposure to shear. The Goodman
et al. model is used in the current research and is discussed further in the Methods section.
The highest shear rate used in the prior computational models was 5800 s-1. This shear
rate was produced in the small diameter of Goodman’s et al. abrupt expansion and contraction
geometry. However, in Goodman’s single pass flow cell, exposure to this shear rate was brief
(~.01 sec) compared with the overall length of the experiment (~120 sec).
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3 Methods
3.1 Geometry
An annular gap between rotating concentric-cylinders was chosen for its machinability and
similarity to an axial flow blood pump (shown in Figure 6). The shear rate within the annular gap
is varied by controlling the rotational speed of the outer cylinder. The maximum shear rate is
9500 s-1, which is typical of an axial flow blood pump and higher than previously tested with this
numerical model. The radial dimensions, angular velocity, and Reynolds number at this shear
rate are listed in Table 2. The annular gap is 0.014 in (0.36 mm) in order to maintain laminar
flow (Re < 1,500) over the range of rotational speeds. The outer cylinder is rotated in order to
avoid any Taylor instabilities [Tritton, 2003].

Figure 6: Flow geometry
Table 2: Flow geometry parameters at max shear Rate of 10,000s-1
Parameter
Value
Inner radius (mm)
16.3
Gap (mm)

0.36

Angular velocity (rad/s)

445

Reynolds number

459

Based on blood viscosity of 3 cp and density of of
1.06 g cm-3
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3.2 Test Rig Design and Construction
A device (Figure 6) was designed and constructed for the purpose of exposing the blood to a
known, constant and controlled shear rate. Natural polycarbonate was chosen for the blood
contacting test section because of its optical clarity and its common usage in blood handling
devices. Appendix F gives a full parts list and drawing package for this test rig.

Figure 7: Test rig assembly, 1: DC motor; 2: Inner cylinder held static; 3: Outer cylinder
mounted in bearings

3.3 Blood Collection
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Fresh, whole bovine blood was collected by relieving the hide and puncturing the carotid
artery. The freely flowing blood was then collected in polyvinyl chloride (PVC) container
containing enough heparin (porcine intestinal mucosa, EMD Chemicals INC (Biosciences),
Darmstadt, Germany) to reach a final concentration of 1.5 U/ml. The blood was then transferred
to a sterile Polyethylene Terephthalate Glycol (PETG) container (VWR International) for
storage. The process was done at a local slaughterhouse in accordance with all USDA
regulations. Appendix D gives a full standard operating procedure for the blood collection.

3.4 Exposing Blood to Shear
Because of the instability of blood, great care was taken to replicate the method for each
individual trial. 2 mL of blood was pipetted from the PETG storage container using a variable
volume pipettor (VWR International). The blood was then placed in the annular gap test section.
The test rig was then turned on and the speed adjusted to the desired rpm. The time from when
the blood is placed in the test section until the desired rpm was reached was 30 seconds for all
trials. The blood was exposed to the desired shear rate for an additional 120 seconds. The blood
was pipetted from the test section and placed in a sterile, borosilicate glass test tube.
Three different shear rates, 2200, 6600, and 9500s-1, were tested in this experiment and
compared to a control of 0 shear (simply exposing the blood to the section). This control was
chosen in order to isolate the effects of shear stress on the whole blood, while including any
effect of exposure to the material. 9500s-1 was chosen as the maximum shear rate Two or three
trials were run at each shear rate. One outlying data point was omitted from the results because
the BBL Fibro System malfunctioned.

20

3.5 Coagulation Measurement
Each whole blood sample was centrifuged for 10 minutes and approximately 1mL of plasma
was collected for each trial. The BBL Fibro System (Becton Dickinson Microbiology Systems,
NJ) was used to measure coagulation by conducting the prothrombin time (PT) and activated
partial thromboplastin time (APTT) tests. PT and APTT are medical standards for measuring
coagulation and detailed methods have been well documented [Stiene-Martin, 1998]. PT
measures the extrinsic pathway, which is activated by exposure to damaged endothelial cells, and
APTT measures the intrinsic pathway, which is activated by exposure to any negatively charged
surface. Both the PT and APTT are indirect measures of prothrombin and thrombin which are the
final and most important factors for fibrin clot formation, and both of these coagulation factors
are included in my computational model. A shorter PT or APTT indicates that more coagulation
factors are present and clot formation is occuring more rapidly. The vise versa is also true. PT
and APTT of the blood were then measured for each stress level. The variance of the test data
“R” was found by linear regression and solved in Microsoft Excel.
After the trials at the highest shear rate, the polycarbonate inner cylinder was inspected for
platelet attachment with microscopy. Directly after each trial, the inner cylinder was rinsed with
a 0.9% NaCl solution. The surface was then stained with Wright stain in order to visualize the
platelets. A Keyence VHX-500 (Keyence Corporation of America, NJ) digital microscope was
used to inspect the surface. An area representing approximately 10% of the total surface area was
inspected.
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4 Computational Methods

4.1 Numerical Methods
The governing fluid equations were solved using a commercially available CFD package,
Fluent 6.3 (Fluent Inc., Lebanon, NH). A control-volume approach was used and the geometry
was discetized into quadrilateral elements. Blood was modeled as a Newtonian fluid with a
viscosity of 3 cp [Goodman, 2005]. The conservation of mass or continuity equation can be
written as Equation 2

r
∂ρ
+ ∇ • (ρu) = Sm
∂t
where

r
u is the velocity vector, ρ

is the density of the fluid and

Equation 2

Sm is the source term to

account for any mass added to the system. This is the general form of the equation and is
applicable to both compressible and incompressible fluids. The general form of the conservation
of momentum equation can be written as Equation 3

()

r
∂ r
(ρu ) + ∇ • (ρurur ) = −∇p + ∇ • τ + ρgr + F
∂t
where

tensor

p

τ

r

is static pressure,

Equation 3

r

ρg and F

are the gravitational and body forces, and the stress

is described in Equation 4
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τ = µ (∇u + ∇u T ) − ∇ • uI 
3




where

r

r

2

r 
Equation 4

µ is the molecular viscosity and I is the unit tensor. The coupled convection-diffusion

equation can be written as Equation 5

r
r
∂
u
C
=
−∇
•
J i + Si
(ρCi ) + ∇ • (ρ i )
∂t
where

Equation 5

Ci is the mass fraction of the ith species, Si is the souce term for the ith species and J i

is given as Equation 6

r
J i = − ρDi,E ∇C i

Equation 6

where Di,E is the enhanced diffusivity for the ith species. Fluent solves each of these equations
iteratively with time to generate the flow field and species concentrations for each grid cell.
The species transport solver in Fluent uses the convection-diffusion equation (Equation
5) to model individual species transport in a flowing medium. This equation is valid for species
with a low (<0.001) mass fraction and particles small enough that they do not disrupt the flow
field. The entire solution process is illustrated in Figure 8. The simulation is started by
initializing the problem by inputting values of initial velocity and species concentrations. Fluent
then performs its first iteration by iterating the momentum, continuity, energy, and species
transport equations. This generates values of the velocity field, shear rate and species
concentration for each grid cell. These values are inputted into the UDF. The UDF then
calculates species concentration based on the souce terms given in Table 3. Fluent then checks
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for convergence by comparing the residual of each equation to the convergence criteria. If the
residual is larger than the convergence criteria, Fluent preforms another iteration beginning by
iterating the equations of fluid motion. If the residual is smaller than the convergence criteria,
Fluent moves to the next physical time step. A listing of the steps taken to implement this model
in Fluent are given in Appendix A.

Figure 8: Flow chart of solution process in Fluent. Items in circles are input or output
values to or from the solver. Items in solid squares are functions performed by the solver.
The dashed line encompasses the loop of functions that Fluent performs each iteration.
The CFD simulation is not an exact representation of the actual physical geometry, so some
assumptions must be made. A CFD is 2-D and therefore assumes that there is a negligible
gradient longitudinally along the cylinder and also neglects the end effects of the bottom of the
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cylinder. Periodic boundary conditions were used to reduce the computational domain and
assume a negligible circumfirencial gradient due to the symmetric geometry. The time for the
cylinder to reach full speed is different between the experiment and the CFD and the effects of
these beginning seconds is assumed negligible when compared to the 120 second duration of the
experiment. The flow regime is assumed to be laminar due to the calculated Reynolds number of
450 for the highest shear rate. And finally, while blood is know to be a non-Newtonian fluid it is
assumed to have a constant viscocity because these flow regimes are well above the critical shear
rate 1000 s-1 [Hellums, 1993].
The nondimensionalization of Equation 5 leads to the dimensionless group of the Peclet
number

Pe =

Ua
D

Equation 7

The Peclet number is a measure of relative importance of convective terms to diffusive terms
where U is a characteristic velocity, a is characteristic length and D is normally the Brownian
diffusivity of a species, but for this research the effective diffusivity will be used. A large Peclet
number compared to unity indicates a dominant convective term. For this geometry, the Peclet
number is only dependent on the characteristic length a. For the bulk flow a=3.5e-3 cm and Pe is
on the order of 104 in the circumferential direction. In the radial direction, velocity is close to 0
and Pe is small compared to unity. Therefore, convection is the dominant term for platelet
transport in the bulk flow, but diffusion is dominant for platelet transport in the radial direction.
Also, the velocity near the inner wall will be close to zero while the shear will remain constant,
so a boundary layer exists near the inner wall where diffusion is the dominant term for platelet
transport.
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4.2 Thrombosis Model
4.2.1 Included Species
The species included in the numerical thrombosis model consist of unactivated platelets,
activated platelets and 5 agonists of thrombogenesis (ADP, TxA2, prothrombin, thrombin and
antithrombin). The abbreviation and source terms for each species are given in Table 3. These
species were chosen due to their major role in platelet activation, deposition, and aggregation.
The use of these species was first proposed by the model developed by Hubbell and McIntire
(Hubbell, 1986). While von Willebrand factor has been included in previous models, it is not
included in the current model. The given parameters for each of the species including initial
concentration and Brownian diffusivity Db are given in Table 5.
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#

Table 3: List of included species and their sournce terms
Species
Abbreviation
Bulk Source Term

Boundary SourceTerm

1

Unactivated Platelets

Pl

-kpa [Pl]

-S(x,t)kps [Pl]+Femb M(x,t)

2

Activated Platelets

AP

+kpa [Pl]

-S(x,t)kas [AP]-Ma (x,t)/M∞ kt [AP]

3

Adenosine diphosphate

ADP

+λkpa [Pl]

----

4

Thromboxane A2

TxA2

+st[AP]+kj [TxA2]

+Ma (x,t) st

5

Prothrombin

pT

-[pT](Φat[AP]+Φrt [Pl])

-[pT](Φpt Mu (x,t) + Φat Ma(x,t))

6

Thrombin

T

+[pT](Φat[AP]+Φrt [Pl])-Γ[T]

[pT](Φpt Mu (x,t) + Φat Ma(x,t))

7

Antithrombin III

aT

-Γ[T]

---
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Table 4: List of symbols in Table 3

Symbol

Description

Value

Mu

Concentration of unactivated platelets
on the surface (plt m^-2)

-

Ma

Concentration of activated platelets on
the surface (plt m^-2)

-

M∞

Total capacity of the surface for
platelets (plt m^-2)

-

kps

rate constant for unactivated platelets
adhering to surface (m s^-1)

2.5 x 10-6

kas

rate constant for activated platelets
adhering to surface (m s^-1)

3.5 x 10-3

kt

rate constant for platelets adhering to
other platelets (m s^-1)

3.5 x 10-3

Femb

fraction of surface-adherent platelets
that embolize during each time step

Eq. 1

λ

Amount of ADP released from platelet
granules (nmol / plt)

2.4 x 10-8

st

rate of synthesis of TxA2 (mol [AP]^-1)

9.5 x 10-12

kj

rate of TxA2 inactivation (s^-1)

0.0161

Φat
Φrt
Γ

thrombin generation rate on the
surface of activated platelets (U plt^-1
s^-1 [pT]^-1)
thrombin generation rate on the
surface of unactivated platelets (U plt^1 s^-1 [pT]^-1)
calculated rate for heparin-catalyzed
inactivation of T by aT (mole [T]^-1 s^1)
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6.5 x 10-10
3.69 x 10-9
-

Table 5: Parameters for all the species in the coagulation model.
Species
Pl
AP
ADP
TxA2
pT
T
aT

Initial
Concentration
3 x 108 plt ml-1
1% [Pl]
0 µM
0 µM
1.1 µM
0 µM
2.84 µM

Initial Mass
Fraction
0.0006
0.000006
0
0
0.000075
0
0.000167

MW (g/mol)

Db(cm^2 s^-1)

1.28 x 1012
1.28 x 1012
424.4
352.5
72000
36600
62000

1.58 x 10-9
1.58 x 10-9
2.57 x 10-6
2.14 x 10-6
3.32 x 10-7
4.16 x 10-7
3.49 x 10-7

4.2.2 Platelet Deposition
Platelet deposition and attached platelet agonist release are modeled using a set of boundary
source terms shown in Table 3 in the Boundary Source Term column. These boundary source
terms are written by the user as a User Defined Function (UDF) and each is implemented in
separate convection-diffusion equation (Equation 5). Because these are boundary source terms,
they are only applied to nodes designated as wall nodes.
The kinetic constant of platelet adhesion (kps and kas in Table 3 Boundary Source Terms #1
and #2) is the constant that determines the rate at which platelets adhere to the surface.
Unfortunately, this constant is not widely used and there is little available empirical data.
Previous researchers have used scanning electron microscopy (SEM) to measure platelet
adhesion to polyethylene and fit the numerical data to the experimental data by changing the
constant [Goodman, 2005]. In addition, previous experiments with polyethylene and silicon
rubber lead to the conclusion that the difference in platelet adhesion on polymer surfaces is not
significant [Goodman, 2005] Therefore, this research used the most recently published value for
the kinetic constant of platelet adhesion of 2.5e-6 m s-1 for unactivated platelets and 3.5e-3 m s-1
for activated platelets.
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Platelets have been observed to initially adhere in monolayer on the biomaterial surface
[Grabowski, 1967] and also are more likely to adhere to a surface that is not already populated
by adhered platelets. These phenomena are taken into account by the surface availability function
S(x,t) (Table 3 Boundary Source Term #1 and #2) defined as Equation 8

S ( x, t ) = 1 −

where

M ( x, t )
M∞

Equation 8

M ∞ is the total available surface area and M(x,t) is current surface area occupied by

platelets and shown as Equation 9.

t

M (x, t ) = ∫ S ( x, t )(k ps [Pl ] + k as [ AP ])(1 − Femb )dt

Equation 9

0

When a platelet attaches to the surface, it releases agonists (txA2, pt, th) that further
promote platelet deposition and activation. Attached platelet agonist release is included in this
model as Boundary Source Terms #4, #5, and #6 in Table 3.

4.2.3 Platelet Activation and Agonist Release
Platelet activation and agonist release are governed by the set of source terms shown in Table
3. These source terms are written by the user in a UDF. Each source term is implemented as the
source term in Equation 5. Each species has a separate convection-diffusion equation (Equation
5) with the appropriate source term.
There are two modes of platelet activation included in this model: agonist induced activation
and shear induced activation. Agonist induced activation is dependent upon a weighted
summation of the concentrations of ADP, TxA2, and thrombin. When this summation reaches a
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critical threshold,

k pa

(Bulk Source Terms #1, #2, and #3 in Table 3) changes from 0 to >0 and

platelets begin to activate as shown in Equation 10

k pa

where

Ω

0, Ω < 1.0
= Ω
, Ω ≥ 1.0
tact

is the agonist summation desribed as Equation 11

n

Ω = ∑ wi
i =1

where

aj

Equation 10

[ai ]

Equation 11

[a ]
i ,crit

is the concentration of the jth agonist and

a j ,crit

and

wj

are the critical

concentration for activation and the weight of the jth agonist as shown in Table 6
Table 6: Critical concentrations for activation and weights for agonist induced activation

Species
ADP
TxA2
T

Concentration needed
for activation
2 µM
0.6 µM
0.01 U ml^-1

Weight
1
3.3
220

The rate of platelet activation is proportional to the concentration of the agonists.
Shear induced activation is based on the work of Hellums [Hellums, 1993] and is
described in Equation 12

t = 4 x106τ −2.3
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Equation 12

t is the time to activation and

τ

is the shear the platelet is exposed to (dynes cm-2 ). The time to

activation and the shear stress are tracked in the UDF.
Upon activation, platelets release ADP, TxA2, prothrombin, and thrombin (Bulk Source
Terms #3, #4, #5, #6 in Table 3) which creates a positive feedback loop because these species
further encourage platelet activation. Figure 9 is a flow chart illustrating the feedback loop as
well as the pathways for platelet activation and thrombus formation.
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Figure 9: Schematic of platelet activation and thrombus formation. Solid lines are
pathways to the various platelet states and dashed lines represent the feedback loop due to
agonist release. For clarity, either the equation or the table are listed for each reaction.
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4.2.4 Thrombus Growth
The current model allows for grid cells that contains a higher volume of platelets than the
volume of the grid cell to be converted to a solid. This solid represents a thrombus and does not
allow fluid to flow through the grid element. In this way, a clot can “grow” by converting
adjacent numerical elements to thrombus. Additionally, attached thrombus can also embolize and
attached platelets may return to the bulk flow as unactivated platelets.

4.2.5 Enhanced Platelet Diffusion
The motion of red blood cells (RBC) in flowing whole blood has been observed to enhance
the diffusivity of other particles in the blood [Strong, 1987; Wootton, 2001]. The enhanced
diffusivities for unactivated platelets, activated platelets, prothrombin, thrombin and
antithrombin III were accounted for. The other species (ADP and TxA2) are too small to be
affected by the RBC motion; therefore, the Brownian diffusivity was used for these species. The
diffusion coefficient for each species (enhanced and Brownian) was taken from the literature.
[Sorensen 1999] Following Wootton et al. [2001] the enhanced diffusivity is given as Equation
13

De = Db + βγ
where De is the effective diffusivity, Db is the Brownian diffusivity,
enhancement coefficient (=6.0e-10 cm^2) and

γ

Equation 13

β

is the diffusion-

is the maximum local shear rate. The effective

diffusivity can be several orders of magnitude greater than the Brownian diffusivity for high
shear flows. The Brownian diffusivity for each species is listed in Table 5.
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4.3 Validation of Model by Comparing with Previously
Published Results
The previously published results of flow through an axisymmetric stenosis from Goodman
[2005] were reproduced to ensure that our numerical model was working and implemented
correctly. All of the simulation parameters were exactly replicated with the exception of mesh
size, due to computational expense. We used a mesh size of 2 microns whereas Goodman used
0.5 micron. The geometry of an abrupt contraction and expansion was modeled with a twodimensional, axi-symmetric mesh.

4.4 Numerical Model Applied to Annular Gap
4.4.1 Boundary Conditions
The cylindrical annular gap was solved using a two-dimensional, unsteady, laminar solver in
Fluent. Rotational periodic boundary conditions were used to simulate a 0.048 radian portion of
the geometry (Figure 10). A structured mesh was used to represent this characteristic volume.
The outer wall was set as a rotating boundary condition and the inner wall is a fixed wall. The
bulk fluid is initially at rest, but develops as it is driven by the outer wall rotating at a constant
angular velocity. For a shear rate of 10,000 s-1 , the outer wall was set to rotate at 4000 rpm. Each
simulation was run for 120 seconds for a total of 8000 revolutions.
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Figure 10: Schematic of complete flow geometry compared to computational domain with
labeled boundary conditions 1: Rotational periodic; 2: Stationary wall; 3: Rotating wall

4.4.2 Modifications to the previous model
The following modifications of the implementation of Goodman were made in order to
produce a well posed problem. First, periodic boundary conditions were used. Periodic
boundaries must come in pairs and the paired boundaries are treated as neighbors, so whatever is
the output of one boundary is the input to the other. Secondly, as there was no flow rate or
pressure difference specified for this simulation, the rotating outer boundary is the only cause for
convection. Because there is no inlet boundary condition, a method of inputting initial species
concentration was determined. A user defined function was written that added a second source
term to the diffusion equation. This source term was turned on only for the first time step of the
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simulation and the appropriate initial species concentration was reached. The source was then
turned off and only the original source terms remain.

4.4.3 Model convergence
The rotating boundary problem is a fairly common problem in CFD, especially in the field of
turbomachinery. To produce a converged solution, the rotation boundary condition was set to an
RPM of about 0.5 to 0.25 of the final RPM. A converged solution is reached using a small
numerical time step (1e-5 sec) when compared to the total solution time (120 sec). The RPM is
then raised incrementally and a converged solution is reached for each RPM until the desired
RPM is reached. This “ramp up” method produces a better converged solution with less
computational expense. For this research, the desired RPM was reached in about 1e-3 sec of flow
time.
The simulation was run to convergence criteria of 1e-4 for the weighted residuals of
continuity, velocity and convection-diffusion of each species. The simulation was started with a
time step of 1e-5 sec for stability, and was later incrementally increased to 0.01 sec. The PISO
pressure-velocity coupling proved to be more stable than other methods. The under-relaxation
factors were not changed from the default settings. A grid study comparing shear rate with
element sizes of 10, 5, and 2 microns and a separate grid study comparing platelet depsotion with
element sizes of 10 and 5 microns were conducted. 120 sec of flow time solution required about
48 computer hours on a single 2.8 GHz AMD Opteron processor with 32GB of RAM for a grid
size of 5 microns (5600 grid elements). A solution for a 2 micron grid was attempted. The rate of
solution for one week was interpolated out to determine that 120 sec of flow time would require
~9000 computer hours or about 1 year.
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5 Results

5.1 Experimental
Figure 11 shows the results from the PT and APTT tests described in chapter 3.5 as a
function of shear rate. Although regression showed the data to be statistically insignificant, a
trend of decreasing time is seen from the linear fit lines. The decreasing PT and APTT indicate
that coagulation is occuring more rapidly and higher levels of coagulation factors such as
thrombin and prothrombin are in the blood. The control PT and APTT (0 shear) of these
experiments were approximately 75 and 200 seconds
300

Time for Clot to form (sec)

250

200

150

100

50

APTT

0
0

2000

4000

6000
-1

Shear Rate (s )

Figure 11: Measured PT and APTT
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respectively. The normal PT and APTT are about 12 and 25 respectively. The PT and APTT
were elevated in these experiments by the addition of heparin in an effort to make any changes in
PT or APTT more pronounced. Microscopy showed that no platelets were attached to the
surface.

5.2 Comparison of Numerical Model with Previous Results
The result of the simulation of flow through the stenosis compared very well with the
published results [Goodman, 2005]. Figure 12 illustrates the thrombus growth that is similar in
size, shape and location to that published by Goodman [2005, Fig #13]. The time when the
thrombus reaches this size is about 30% faster in the current model than calculated in the prior
study due to the larger mesh size.
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Figure 12: Top Left: Schematic of Goodman et al. geometry showing line of symmetry in
red. Bottom Left: Resulting simulation done as a part of this work, showing attached
thrombus. The colors identify the grid cells as fluid (blue and light blue), and thrombus
(red and yellow). Right: Experimental (A and B) and computational (C) results from
Goodman 2005, pg 788 showing attached thrombus. Note similarity in both size and
location to Goodman et al. results.

5.3 Annular Gap
5.3.2 Grid Study
A grid study of only the fluid motion was conducted. Less than a 1% change in the wall
shear rate was observed when the grid elements were reduced in size from 10 microns to 2
microns. Figure 13 and Figure 14 are plots of the wall strain rates for the 3 grid sizes. Note the
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Figure 13: Shear rate at the stationary (inner) wall for three different grid sizes. Less than
1% change was observed from the 10 micron grid to the 5 micron grid.

increase in deviation when the grid is reduced from 5 microns to 2 microns. There are two
potential causes for this increase in deviation. First, it is possible that when a grid is smaller than
a critical size, the numerical error increases as the grid size decreases. Future work could consist
of a grid study to determine the critical grid size. A more likely cause of this increase in scatter is
inability for the 2 micron simulations to converge to the same residual as the 10 and 5 micron
grids. The 10 and 5 micron grids converged to a residual of 1e-5 for continuity while the 2
micron grid could only converge to a residual of 1e-4 for continuity.
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Figure 14: The shear rate at moving (outer) wall for three different grid sizes. Less than
1% change was observed from the 10 micron grid to the 5 micron grid.
Another grid study using the entire thrombosis model was then conducted with grid elements of
10, and 5 microns. Platelet deposition on the wall at 100 sec of flow time was measured for each
grid. Platelet deposition for the 10 micron grid was over 3 times higher near the center of the
domain than at the boundaries. The asymmetry observed in the 10 micron grid was eliminated
when the grid size was reduced to 5 microns as shown in Figure 15. For this reason, a grid size of
5 microns was used for all simulations.
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Figure 15: Normalized platelet deposition on the stationary (inner) wall for grid elements
of 10 and 5 microns. Platelet Deposition is normalized to the minimum value for each
simulation for comparison purposes.

5.3.2 Velocity Field
The annular gap geometry generated expected flow properties. The steady-state velocity
profile was linear, which resulted in a near uniform shear across the entire domain. Because the
fluid is initially at rest, there is a transitional period in the fluid before it reaches a steady state
velocity profile (Figure 16). The development time (~0.025 seconds) is short compared to the
total solution time (>60 seconds) and any shear stresses imparted by this transitional period have
minimal impact on the final solution.
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Figure 16: CFD velocity profile development

5.3.3 Platelet Concentrations
Platelet mass was conserved to within 3% over the 120 sec simulation. This change is
likely due to round-off error of the solver.
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Figure 17: Total number of platelets in the simulation at 0.0005, 0.5, 1, 10, 30, and 100
seconds. The number of platelets deposited on the moving and stationary wall is less than
3% different than the number of plates lost from the bulk flow at any time.
The mass fraction of resting and activated platelets in the bulk flow decreases over time due
to platelet deposition. Figure 18 illustrates the higher rate of deposition for activated platelets
compared to resting platelets.
Over the three shear rates tested, the mass fraction of thrombin was observed to increase with
increasing shear (Figure 20). This increase in thrombin is due higher levels of platelet activation
and deposition.
Most of the species including thrombin maintained a nearly uniform concentration
throughout the solution. However, after several seconds of flow time, a concentration gradient
developed for activated and unactivated platelets across the domain. The center of the domain
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contained a high concentration of platelets while platelet concentration was low near the walls as
shown in Figure 19. This is due to the fact that the walls act as a sink for the platelets. As
platelets deposit on the wall, platelet concectration in the bulk flow near the wall decreases. As
this process continues in time, a gradient develops with the highest concentration of platelets in
the center of the flow.
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Figure 18: The mass fraction of activated and resting platelets decrease over time in the
CFD simulations.
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Figure 19: Activated platelet concentration for the entire computational domain at 100 sec
of flow time. Note the high concentration in the center and low concentration near the
walls.
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Figure 20: Results from computational simulations demonstrating increasing thrombin
mass fraction with increasing shear rate. Each point represents an individual CFD
simulation of 120 seconds of solution time.
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6 Conclusion and Discussion
6.1 Experimental Insight and Discussion
After exposing whole blood to a specific shear for 120 seconds, PT and APTT were
measured as described in chapter 3.5. These tests provide a measure of time until clot formation
and relative amounts of coagulation factors. A decrease in PT and APTT would indicate more
rapid clot formation and higher levels of coagulation factors. Therefore, the results shown in
Figure 11 indicate that blood exposed to high shear rate contains more coagulation factors than
blood exposed to a lower shear rate.

6.2 Numerical Insight and Discussion
Three separate numerical simulations were solved with three different shear rates. As the
simulation progessed in time, the flow field and the biomaterial surface interacted with the
species to simulate coagulation as described in chapter 4. In the numerical model, thrombin is
generated due to platelet activation and platelet deposition as governed by the source terms in
Table 3. Figure 20 demonstrates that thrombin concentration in the numerical model increases
with increasing shear rate. Therefore, increasing shear is causing more platelet activation and
more platelet deposition.

However, increasing the shear rate also increased the rate of

embolization, so no significant difference in thrombus growth was observed. Another, interesting
insight is the non-zero thrombin concentration for the 0 shear simulation. This indicates that the
numerical model is capable of modeling the effect of a biomaterial surface without a flow field.
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6.3 Comparison of Numerical and Experimental Results
The trend seen in the experimental results of PT and APTT decreasing with increasing shear
indicate that higher levels of coagulation factors are present. This is in agreement with the
numerical models prediction of increasing thrombin and other coagulation factors with
increasing shear rate. This agreement indicates that the numerical model can qualitatively predict
the effects of shear on whole blood. A qualitative evaluation of the numerical model will require
further research with more suffisticated experiments. This initial evaluation of the numerical
coagulation model is necessary to guide future research with the ultimate goal of applying this
model to a mechanical blood pump.

6.4 Future Improvements to the Experiment
The experimental method and test rig described in this thesis is a baseline for developing an
experimental apparatus that can conduct controlled experiments studying whole blood in a high
shear flow field. Ultimately, this apparatus will be similar to a commercial ventricular assist
device (VAD). Immediate improvements would include: the direct measure of coagulation
factors, a geometry that induced thrombus formation, and a controller for the DC motor. The
validation of the numerical model would benefit from experimentation that directly measured
values of the individual coagulation factors that are included in the numerical model. A geometry
that included areas of high and low shear would be a better representation of the blood pathway
through a poorly designed assist device that is more likely to produce a clot. This geometry
would provide more information on platelet deposition and thrombus growth that is more readily
seen in clinical applications. A computer controlled DC motor could provide some interesting
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experiments such as pulsing the motor on and off. Experiments such as this can demonstrate the
effect repeated exposure to high (implanted VAD device) and low (venous return) shear on
whole blood.

6.5 Potential Improvements to the Current Numerical Model
One area of possible improvement to this computational model is the threshold nature of
platelet activation. It has been shown that weak agonists (ADP, epinephrine, etc.) and strong
agonists (thrombin, etc.) act synergistically, and that different concentration combinations of
each have varying effects [Huang, 1981]. The synergist effect of agonists is current not included
in the model at all.
In the current model, agonist induced activation and shear induced activation are two
completely separate modes of platelet activation. It has been shown that a sub-critical
concentration of agonists combined with a sub-critical shear rate can produce significant
amounts of platelet activation. [Anderson, 1978] This synergistic effect of shear and agonists
could be large source of error for this numerical model. While incorporating the synergistic
effects would be the best solution, perhaps a more efficient use of resources would be to
determine the regimes that these synergistic effects would be most influential and evaluate if the
current numerical model can be applied in these regimes.
The experiment and the numerical model both showed no signs of clot formation. This is
likely due to the high shear washing the surface. This agrees with Goodman et al. experimental
data on embolization (Equation 1). According to Goodman et al., at the shear rate and exposure
time tested, less than 5% of platelets would remain attached. This type of flow, while uniform
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and controllable, does not promote thrombogenesis. This numerical model is best suited for
comparing with experiments that encourage platelet deposition and clot formation.
In the future, a similar comparison of numerical and physical models should be made for a
high shear rotating flow that also includes regions of stagnation or recirculation.
The current numerical model only contains two factors of the coagulation cascade
(prothrombin and thrombin). These two factors are part of the common pathway (coagulation
factors that are in the extrinsic and intrinsic pathways). While these two factors are precursors to
thrombus formation, the model would benefit from the inclusion of other coagulation factors
from the individual pathways.
The current research is an effort to characterize the applicable domain of this numerical
model. Further investigation into potential applications would greatly benefit the progess of this
model. Future work could include a parametric analysis of the current research’s results to
determine the relative importance of individual species to a particular application or flow regime.

6.6 Potential Clinical Applications of the Numerical Model
As CFD becomes more robust and computational power becomes cheaper, geometries are
becoming more physiologically realistic. The applicability of this model to physiological
applications has currently not been tested. However, there are several clinical applications that
possess a large potential for this model and should be investigated. Some well studied clinical
cases that thrombosis plays a large role include: vascular stents [Czemak, 2004], aneurysms
[Nagai, 2008], and the internal carotid artery bifurcation [Kanazawa, 2004]. Each of these cases
has several publications that provided in vivo computed tomography (CT) measurements of an
attached thrombus that can readily be compared with CFD simulations of a similar geometry.
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Appendix A Implementation into Fluent
The following is a case specific guide to loading and solving the
Concentric Cylinder case file in Fluent 6.3.2.
1.
2.
3.
4.

Read the .cas file.
Check the grid
Scale the grid – I used 1e-3 for both x and y.
Choose the correct solver: Define – Models – Solver
a. Unsteady
b. All others are default
5. Turn species transport on: Define – Model – Species – Transport and
Reaction
a. Species Transport
b. Volumetric
c. Wall Surface
d. Mass Deposition Source
6. Compile and Load the UDF: Define – User Defined – Functions –
Compiled
a. Click Add
i. Select your C-code file from the list and click OK
b. Library Name is the name of the folder that will be created and
contain the compiled UDF files. A directory of the same name
should already exist in the working directory.
c. Click build
i. A prompt will appear to make sure the C-code file and the
mesh or case file are in the same directory. Make sure this
is true and click OK
ii. If it builds correctly, the Fluent screen should look like
this:

I

d. Click Load
i. If it works correcly,
something like this:

II

the

fluent

screen

should

look

7. Set Function Hooks: Define – User Defined – Function Hooks
a. Click edit next to Adjust
i. select “adjust:libudf” and click add. Then click OK.
b. Click the drop down arrow next to Surface Reactions
i. Select surface_reactions::libudf
8. Set User Defined Memory allocations: Define – User Defined – Memory
a. 17 – this number must be exacly correct or you will get errors
when you attempt to iterate.
i. This is the number of memory allocation set in the UDF

III

9. Define the material: Define –Material all of the commands below are
in the Materials panel
a. Material Type – mixture
i. Change Density to volume-weighted-mixing-law
ii. Click Change/Create
b. Material Type – Fluid
i. Copy liquid water from the Fluent Database
ii. Change the name to blood
iii. Delete the Chemical Formula
iv. Density – 1056
v. Click Change/Create and Overwrite H20
c. Now enter each individual species (rp, ap, dp, adp, txa2, pt, th,
at) with their molecular weights. The Material Type should be
Fluid for all species
i. Enter the species name in the Name box e.g. rp
ii. Enter the molecular weight from Table 5
iii. Click Change/Create and don’t overwrite
iv. Repeat
d. Material Type – Mixture
i. Mixture Species – Edit
1. Move the species from the Available Materials box to
the Selected Species box in the following order : rp,
ap, ADP, txa2, pt, th, at, blood (this must be the
same order they are listed the UDF code)
2. remove any other species that are in the Selected
Species box
3. Move dp to the Selected Solid Species box.
4. click OK
ii. Reaction – Edit
1. Use arrows to change values in this menu
2. Total Number of Reactions – 4
3. Reaction Type – Wall Surface
a. Make sure to click the Wall Surface radio
button for all four of the reactions.
4. Enter the following stoichiometry reactions in the
given order. All Rate Exponent values should be
zero.
a. Reaction 1
i. Reactants:1 rp
ii. Products: 1 dp
b. Reaction 2
i. Reactants: 1rp
ii. Products: 1dp
c. Reaction 3

IV

10.
a.

b.

c.
d.

i. Reactants: 0 ap
ii. Products: 0ap + 1 txa2
d. Reaction 4
i. Reactants: 1 pt
ii. Products: 1 th
e. All Arrhenius Rate values should remain as
defaults
5. Click OK
iii. Viscosity – User Defined
iv. Mass Diffusivity – User Defined
v. Click Change/Create and Close the Materials Window
Set Boudary Conditions: Define – Boundary Conditions
Bot wall
i. Species Tab
1. Check the Reaction box
Fluid
i. Reaction box should be checked if it is not already
ii. Check the Source Terms box
iii. Source Terms Tab
1. Click the Edit box next to the species you wish to
add a source term to.
2. Select the source term for the appropriate species
given in the list below
a. rp – rp_source and rp_init
b. ap – ap_source and ap_init
c. adp – adp_source
d. txa2 – txa2_source
e. pt – pt_source and pt_init
f. th – thrombin_source
g. pt – at_source and at_init
3. click OK
Outs
i. Change the Periodic Type to Rotational
Topwall
i. Click the Moving Wall radio button
ii. Click the Absolute and Rotational radio buttons
iii. Enter the desired rotational speed in rad/sec
1. For high rotational speeds and shear rates, it can
help the stability of the problem to start at a low
rotational speed, solve the velocity field, and then
raise the rotational speed and continue solving.
Sometimes many small steps like this are necessary
to avoid a divergent solution.

V

2. For a shear rate of 10,000 s-1 a rotational speed of
220 rad/sec is used.
iv. Species Tab
1. Check the Reaction check box
e. Close the Boundary Condition Window
11.
Set Solution Controls: Solve – Controls – Solution
a. Different computers require different Under-relaxation factors
and Pressure-velocity coupling. I have had mixed results using
the PISO and SimpleC couplers. Sometimes they work great and
other times the solution divergese. But when they do work, they
solve much faster than Simple. It is a good idea to lower the
Momentum, rp, and ap Under-relaxation factors to about half of
their default values.
b. Click OK
12.
Initialize the problem: Solve – Initialize – Initialize
a. Compute From – all zones
b. For the given rotational speed of the outer wall or topwall
determine the average steady state velocity and enter this in Yvelocity box
c. Click Init and Close the Initialization Window
13.
Set the Residuals: Solve – Monitors – Residual
a. Set continuity, x-velocity, y-velocity and rp to 1e-5. Set ap to
5e-5.
b. Click OK
14.
Solve the Problem: Solve - Iterate
a. Click the Adaptive Time Step radio button
b. Enter the desired number of time steps
c. I have not had good luck trying to start the simulation with a
time step larger than 1e-5.
d. Change the Max Iterations per Time Step to 200
e. Leave the Adaptive Time Step Parameters as default
f. Click Iterate
15.
When the solution has completed, perform the necessary post
processing.

VI

Appendix B Some notes on Compiling the UDF

On a 64-bit machine running Windows x64, the full version of Visual
Studio is needed to compile a UDF. Visual Studio 2005 Standard Edition
was used for the current research. On a 32-bit machine, Visual Studion
Express can be used and is a free download from Microsoft. Fluent must
be opened in the Visual Studio command prompt (x64 Win64 command
prompt for 64-bit machines) that is located in the Visual Studio Tools.

VII

Appendix C Source Code
/*User-Defined Functions*/
#include "udf.h"

/* global variables */
/* physical constants, misc.*/
int wall1_ID = 5;
int wall2_ID = 6;
int interior_ID = 8;
real flow_rate = 0;
real visc =.00325;
int partition = 2;
/* platelet info */
real plt_count = 300.;
real minf = 6.0e10;
real test;
/* kinetic variables */
int thrombus_count = 1;
real krs = 0.0000025;
real kas = 0.0035;
real kt = 0.0035;
real tact = 1.0;
real temb = 120.0;
/* global time for initial concentrations */
real delt_int = 0.00001;
/* User-Defined Memory Allocations. This stores the data to access it later. */
int M=0;
/*C_UDMI(c,t,0)=M(x,t), total platelet surface coverage (plt/m^2)*/
int Sa=1;
/*C_UDMI(c,t,l)=Sa(x,t), unitless, % avalailable surface area ()*/
int rpadh=2;
/*C_ MI(c,t,2)=flux of unact. plts to the surface (plt/ ^2-s)*/
int apadh=3;
/*C_UDMI(c,t,3)=flux of act. platelets to the surface (plt/m^2-s)*/
int upemb=4;
/*C_UDMI(c,t,4)=flux of act. pits embolizing (plt/m^2-s)*/
int delthu=5;
/*C_UDMI(c,t,5)=delta thrombus, unitless, change in vol% of grid
cell changing to unactivated thrombus */
int delth=6;
/*C_UDMI(c,t,6)=delta thrombus, unitless, change in volume% of grid
cell changing to thrombus */
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int thrombus=7; /*C_UDMI(c,t,7)=thrombus growth, unitless, % of grid cell that is
thrombus () */
int gridid=8;
/*C_UDMI(c,t,8)=grid cell type (bulk fluid, thrombus, etc.,
unitless () */
int tcount=9;
/*C_UDMI(c,t,9)=thrombus_count, unitless, identifies the cell as part of a
numbered thrombus () */
int area=10;
/*C_UDMI(c,t,l0)=wall surface area (m^2) */
int pltact=11;
/* C_UDMI(c,t,11)=platelet activation, calculated from weighted agonist
concentrations, kg/m^3 */
int gama=12;
/*C_UDMI(c,t,12)=maximum local shear rate in cells adjacent to surface
(1/s) */
int Xact=13;
/*C_UDMI(c,t,13)=fraction of thrombus/wall that is act. platelets*/
int actime=14;
/*C_UDMI(c,t,14)=time at which a grid cell becomes active (s)*/
int Ma = 15;
/*C_UDMI(c,t,15)=Ma(x,t), act. platelet surface coverage (plt/m2)*/
int Matime = 16;/*C_UDMI(c,t,16)= time at which the surface of the cell becomes active*/
/* end global variables */

/* Adjust Function keeps track of thrombus*/
/* growth, platelet adhesion, etc.*/

static int last_ts = -1;
step*/

/* this global variable is used to identify the first iteration in a time

DEFINE_ADJUST(adjust,d)
{
Thread *t, *tc1, *ft, *tc0;
cell_t c, c1, c0;
face_t f;
real delt,curr_t,A[ND_ND],total_force[ND_ND], adhesion_area;
int curr_ts, n, th, new, old,p,neighbor;
new = 0;
old = 0;
curr_ts = RP_Get_Integer("time-step");
delt = RP_Get_Real("physical-time-step");
curr_t=RP_Get_Real("flow-time");

/*The following if loop ensures that the adjust function is calculated only once per
time step */

if (last_ts != curr_ts)
{

IX

last_ts = curr_ts;
thread_loop_c(t, d)
{
if (FLUID_THREAD_P(t)) /* applies adjust function only to fluid threads*/
{
/* Initialization performed only on the first time step*/
if(curr_t==delt)
{
thrombus_count = 1; /*initialize the thrombus ID number*/
begin_c_loop_int(c,t) /*the int applies the loop to cells that are
inside the partition*/
{
C_UDMI(c,t,Sa)=1.; /*initialize Sa(t)*/
C_UDMI(c,t,area) = 0.0;
/* initialize area calculation*/
c_face_loop(c,t,n)
{
f=C_FACE(c,t,n);
ft=C_FACE_THREAD (c,t,n);
if(THREAD_ID(ft)==wall1_ID
||
THREAD_ID(ft)==wall2_ID)
{
F_AREA(A,f,ft);
C_UDMI(c,t,area) += NV_MAG(A);
C_UDMI(c,t,actime)=0.;
}
}
}
end_c_loop_int(c,t)
}
/*end first step initialization*/
/* General cell loop to determine thrombus growth, max shear, grid cell type (i.e. thrombus),
and to identify individual thrombi numerically */

begin_c_loop(c,t)
{
/*calculate the cumulative thrombus growth */
C_UDMI(c,t,thrombus)=C_UDMI(c,t,thrombus)
(C_UDMI(c,t,delth)+C_UDMI(c,t,delthu)) * delt;
if(C_UDMI(c,t,thrombus)>=1. )
C_UDMI(c,t,thrombus)=1.;
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/* calculate the shear rate in all cells */
if (abs(C_DUDX(c,t)) > abs(C_DUDY(c,t)) &&
abs(C_DVDX(c,t)) && abs(C_DUDX(c,t)) > abs(C_DVDY(c,t)))
C_UDMI(c,t,gama) = abs(C_DUDX(c,t));
if (abs(C_DUDY(c,t)) > abs(C_DUDX(c,t)) &&
abs(C_DVDX(c,t)) && abs(C_DUDY(c,t)) > abs(C_DVDY(c,t)))
C_UDMI(c,t,gama) = abs(C_DUDY(c,t));
if (abs(C_DVDX(c,t)) > abs(C_DUDY(c,t)) &&
abs(C_DUDX(c,t)) && abs(C_DVDX(c,t)) > abs(C_DVDY(c,t)))
C_UDMI(c,t,gama) = abs(C_DVDX(c,t));
if (abs(C_DVDY(c,t)) > abs(C_DUDY(c,t)) &&
abs(C_DVDX(c,t)) && abs(C_DVDY(c,t)) > abs(C_DUDX(c,t)))
C_UDMI(c,t,gama) = abs(C_DVDY(c,t));

abs(C_DUDX(c,t))

>

abs(C_DUDY(c,t))

>

abs(C_DVDX(c,t))

>

abs(C_DVDY(c,t))

>

/* identify cells as
(0) interior fluid;
(1) wall fluid;
(2) wall thrombus;
(3) interior thrombus;
(4) interior fluid with thrombus neighbor; and
(5) wall fluid with thrombus neighbor */
C_UDMI(c,t,gridid) = 0;
if (C_UDMI(c,t,thrombus)==1.)
{
C_UDMI(c,t,gridid) = 3;
if(C_UDMI(c,t,actime)==0. && C_UDMI(c,t,gama)>0.)
C_UDMI(c,t,actime)=
curr_t+4.0e6*pow(C_UDMI(c,t,gama)*0.035,-2.3);
if(curr_t >= C_UDMI(c,t,actime) || C_UDMI(c,t,pltact)>0.)
C_UDMI(c,t,Xact)= 1.;
}
c_face_loop(c,t,n)
{
ft=C_FACE_THREAD(c,t,n);
f=C_FACE(c,t,n);
c0 = F_C0(f,ft);
tc0 = F_C0_THREAD(f,ft);
c1 = F_C1(f,ft);
tc1 = F_C1_THREAD(f,ft);
if (PRINCIPAL_FACE_P(f,ft))
{
if(THREAD_ID(ft)==wall1_ID
THREAD_ID(ft)==wall2_ID)
{
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if (C_UDMI(c,t,thrombus) == 1.)
C_UDMI(c,t,gridid) = 2;
if (C_UDMI(c,t,thrombus) < 1.)
{
if(C_UDMI(c,t, gridid)!=5 )
C_UDMI(c,t,gridid) = 1;
/* calculate the new M(x,t) value: M = M+(jr+ja-Memb)*delt */

C_UDMI(c,t,M)=C_UDMI(c,t,M)+(C_UDMI(c,t,rpadh)+C_UDMI(c,t,apadh)C_UDMI(c,t,upemb))*delt;
if (C_UDMI(c,t,M) > minf)
C_UDMI(c,t,M) = minf;
/* calculate the new fraction of activated platelets value*/
C_UDMI(c,t,Ma) = C_UDMI(c,t,Ma) +
C_UDMI(c,t,apadh)*delt;
/*calculate the new Sa(t) value: Sa=1-M/minf*/
C_UDMI(c,t,Sa)=1.-C_UDMI(c,t,M)/minf;
if (C_UDMI(c,t,Sa)<0.)
C_UDMI(c,t,Sa)=0.;
if(C_UDMI(c,t,Matime)==0.
&&
C_UDMI(c,t,gama)>0.)
C_UDMI(c,t,Matime)
=
4.0e6*pow(C_UDMI(c,t,gama)*0.035,-2.3);
if(curr_t >= C_UDMI(c,t,Matime) &&
C_UDMI(c,t,Matime)>0.)
{
C_UDMI(c,t,Ma)=C_UDMI(c,t,M);
if(C_UDMI(c,t,actime)==0.
&&
C_UDMI(c,t,gama)>0.)
C_UDMI(c,t,actime)
=
4.0e6*pow(C_UDMI(c,t,gama)*0.035,-2.3);
if(curr_t >= C_UDMI(c,t,actime)
&& C_UDMI(c,t,actime)>0.)
C_UDMI(c,t,Xact)=1.;
}
}
}
if (THREAD_ID(ft)==interior_ID)
{
if (C_UDMI(c0,tc0,thrombus) == 1. &&
C_UDMI(c,t,gridid) == 0 && C_UDMI(c,t,thrombus)< 1.)
{
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C_UDMI(c,t,gridid) = 4;
C_UDMI(c,t,tcount)=C_UDMI(c0,tc0,tcount);
/*C_UDMI(c,t,tcount) is the thrombus*/
}
if (C_UDMI(c1,tc1,thrombus)
C_UDMI(c,t,gridid) == 0 && C_UDMI(c,t,thrombus)< 1.)
{
C_UDMI(c,t,gridid) = 4;
C_UDMI(c,t,tcount)=C_UDMI(c1,tc1,tcount);
}
if (C_UDMI(c0,tc0,thrombus)
C_UDMI(c,t,gridid) == 1 && C_UDMI(c,t,thrombus)< 1.)
{
C_UDMI(c,t,gridid) = 5;
C_UDMI(c,t,tcount)=C_UDMI(c0,tc0,tcount);
}
if (C_UDMI(c1,tc1,thrombus)
C_UDMI(c,t,gridid) == 1 && C_UDMI(c,t,thrombus)< 1.)
{
C_UDMI(c,t,gridid) = 5;
C_UDMI(c,t,tcount)=C_UDMI(c1,tc1,tcount);
}
}
}
}
/*end of the face loop and if principle_f */
}
end_c_loop(c,t)
/* End of the general cell loop*/

/* Verify that each existing thrombus has a unique identification */

/* to avoid duplication, each partition is evaluated serially */
for(p=0; p <= partition-1; p++)
{
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thrombus_count=PRF_GIHIGH1(thrombus_count);
if (p==myid)
{
begin_c_loop(c,t)
{
if(C_UDMI(c,t,thrombus)==1.)
{
neighbor = 0;
if(C_UDMI(c,t,tcount)==0)
{
c_face_loop(c,t,n)
{
ft=C_FACE_THREAD(c,t,n);
f=C_FACE(c,t,n);
c0 = F_C0(f,ft);
tc0 = F_C0_THREAD(f,ft);
c1 = F_C1(f,ft);
tc1 = F_C1_THREAD(f,ft);
if(THREAD_ID(ft)==interior_ID)
{
if (C_UDMI(c0,tc0,tcount)==0)
{
if
(C_UDMI(c1,tc1,tcount)==0)
{
neighbor = 0;
/*Message ("new thrombus \n");*/
}
else
{
C_UDMI(c,t,tcount)=C_UDMI(c1,tc1,tcount);
neighbor = 1;
/*Message ("neighbor to thrombus %d\n",C_UDMI(c,t,tcount)); */
}
}
else
{
C_UDMI(c,t,tcount)=C_UDMI(c0,tc0,tcount);
neighbor = 1;
/*Message ("neighbor to thrombus %d\n.", C_UDMI(c,t,tcount)); */
}
}
}
/*end of face loop*/
if (neighbor==0)
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{
C_UDMI(c,t,tcount)=thrombus_count;
thrombus_count=thrombus_count + 1;
/*Message ("new thrombus value assigned");*/
}
}
}
}
end_c_loop(c,t)
}
PRF_GSYNC(); /* global sycncronization to make the for loop work across
partitions */
}
/*end for loop*/
/* calculate the force on thrombi, and determine the probability of embolization */
for(th=1; th <= thrombus_count-1; th++)
{
NV_VS(total_force, =, total_force, *, 0.);
test = 0.;
adhesion_area=0.;
begin_c_loop(c,t)
/*loops over the cells in the fluid thread*/
{
if(C_UDMI(c,t,tcount)==th)
{
if (C_UDMI(c,t,gridid)>= 2)
{
c_face_loop(c,t,n)
{
ft=C_FACE_THREAD(c,t,n);
f=C_FACE(c,t,n);
c0 = F_C0(f,ft);
tc0 = F_C0_THREAD(f,ft);
c1 =F_C1(f,ft);
tc1 = F_C1_THREAD(f,ft);
if (THREAD_ID(ft)==interior_ID)
{
/*if thrombus neighbor, calculate the net force on the thrombus*/
if
(C_UDMI(c,t,gridid)
==
4
||
C_UDMI(c,t,gridid)==5)
{
if (C_UDMI(c0,tc0,thrombus) == 1.)
{
F_AREA(A,f,ft);
NV_V_VS(total_force,
=,
total_force, +, A, *, F_P(f,ft));
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/*Message ("pressure at c0 face is %d\n",F_P(f,ft));*/
}
if (C_UDMI(c1,tc1,thrombus) == 1.)
{
F_AREA(A,f,ft);
NV_V_VS(total_force,
=,
total_force, -, A, *, F_P(f,ft));
/*Message ("pressure at c1 face is %d\n",F_P(f,ft));*/
}
} /*end if thrombus neighbor*/
/*check thrombi for adjacent thrombi and merge them*/
if
(C_UDMI(c,t,gridid)
==
2
||
C_UDMI(c,t,gridid) == 3)
{
if
(C_UDMI(c0,tc0,tcount)
<
C_UDMI(c,t,tcount) && C_UDMI(c0,tc0,tcount) != 0)
{
old = C_UDMI(c,t,tcount);
new
=
C_UDMI(c0,tc0,tcount);
C_UDMI(c,t,tcount)
=
C_UDMI(c0,tc0,tcount);
/*Message
("neighbor
found
c0
%d,%d,%d\n",old,
new,
thrombus_count);*/
/*begin_c_loop(c,t)
{
if (C_UDMI(c,t,tcount) == new)
C_UDMI(c,t,tcount) = old;
}
end_c_loop(c,t) new = 0;
old = 0;*/
}
if (C_UDMI(c1 ,tc1,tcount) <
C_UDMI(c,t,tcount) && C_UDMI(c1,tc1,tcount) != 0)
{
old = C_UDMI(c,t,tcount);
new
=
C_UDMI(c1,tc1,tcount);
/*Message ("neighbor found c1 %d,%d,%d\n",old, new,
thrombus_count);*/
C_UDMI(c,t,tcount)
=
C_UDMI(c1,tc1,tcount);
/*begin_c_loop(c,t)
{
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if
(C_UDMI(c,t,tcount) == new)
C_UDMI(c,t,tcount)
= old;

}

}
end_c_loop(c,t)
new=0;
old = 0;*/
}
/*end if thrombus*/

}
}
/*begin_c_loop(c,t)
{
if (C_UDMI(c,t,tcount) == new)
C_UDMI(c,t,tcount) = old;
}
end_c_loop(c,t)
new = 0;
old = 0;
if (new != 0)
C_UDMI(c,t,tcount)=new;
new = 0;*/
}
}
if (C_UDMI(c,t,tcount) == th && C_UDMI(c,t,gridid)==2)
{
adhesion_area=adhesion_area+C_UDMI(c,t,area);
}
}
end_c_loop(c,t)
PRF_GRSUM1(adhesion_area);
test = NV_MAG(total_force);
PRF_GRSUM1(test);
test = test*0.1/adhesion_area;
if(test>0.0)
{
Message ("thrombus id = %d\n", th);
Message ("total force (dyne/cm^2) = %g\n", test);
Message ("adhesion area = %g\n", adhesion_area);
Message ("neighbor found %d\n",new);
}
if (test > 500.)
{
begin_c_loop(c,t)
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{
if (C_UDMI(c,t,gridid) == 5 || C_UDMI(c,t,gridid) == 2 ||
C_UDMI(c,t,tcount) == th)
{
C_UDMI(c,t,gridid) = 1;
C_UDMI(c,t,M) = 0.;
C_UDMI(c,t,thrombus) = 0.;
C_UDMI(c,t,tcount) = 0;
}
if (C_UDMI(c,t,gridid) == 4 || C_UDMI(c,t,gridid) == 3 ||
C_UDMI(c,t,tcount) == th)
{
C_UDMI(c,t,gridid) = 0;
C_UDMI(c,t,M) = 0.;
C_UDMI(c,t,thrombus) = 0.;
C_UDMI(c,t,tcount) = 0;
}
}
end_c_loop(c,t)
}
/* end for loop*/

}
if (new !=0)
{
begin_c_loop(c,t)
{
if (C_UDMI(c,t,tcount) == new)
C_UDMI(c,t,tcount) = old;
}
end_c_loop(c,t)
new = 0;
old = 0;
}
}
}
}
}
/* Define Viscosity of the blood/thrombus */
DEFINE_PROPERTY(cell_viscosity,c,t)
{
real mu_lam;
/* set viscosity to 100 if the cell is thrombus*/
mu_lam = visc;
if (C_UDMI(c,t,thrombus)>=1.)
mu_lam = 100.;
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return mu_lam;
}
/* Define Inlet Velocity Profile*/
/*DEFINE_PROFILE(inlet_profile,thread,position)
{
real x[ND_ND], y;
face_t f;
begin_f_loop(f,thread)
{
F_CENTROID(x,f,thread);
y=x[1];
/*v = 2Q/A(1-(r/R)^2)*/
/*F_PROFILE(f,thread,position)= flow_rate*0.1179*(1-y*y/9.0e-8);
}
end_f_loop(f,thread)
}*/

/* Source Term for Unactivated Platelets */

DEFINE_SOURCE(rp_source,c,t,dS,eqn)
{
real source,omega,area,thrombus,A[ND_ND];
int n;
face_t f;
cell_t c1, c0;
Thread *ft, *tc1, *tc0;
/* calculate bulk platelet activation

*/

omega=528000.*(2.357 *C_YI(c,t,2)+9.362*C_YI(c,t,3)+6.01*C_YI(c,t,5));
if (omega > 1)
C_UDMI(c,t,pltact)=omega/tact*C_YI(c,t,0)*1056.;
/* kg/m^3*/
else
C_UDMI(c,t,pltact)=0.;
/* calculate source term for each cell

*/

if (C_UDMI(c,t,gridid)==0)
source = - C_UDMI(c,t,pltact);
/* kg/m"3*/
if(C_UDMI(c,t,gridid)==1 || C_UDMI(c,t,gridid)==5)
{
/*initialize so grid cells with two wall sides can be correctly counted*/ area=0.;

XIX

thrombus = 0.;
c_face_loop(c,t,n)
{
ft=C_FACE_THREAD(c,t,n);
f=C_FACE(c,t,n);
c0 = F_C0(f,ft);
tc0 = THREAD_T0(ft);
c1 =F_C1(f,ft);
tc1 = THREAD_T1(ft);
if (PRINCIPAL_FACE_P(f,ft))
{
if(THREAD_ID(ft)==interior_ID)
{
if (C_UDMI(c0,tc0,gridid) == 2 || C_UDMI(c0,tc0,gridid) == 3)
{
F_AREA(A,f,ft);
area = NV_MAG(A);
thrombus
=
thrombus
+
C_UDMI(c0,tc0,Xact)*kt*C_YI(c,t,0)* 1056*area/C_VOLUME(c,t); /*kg/m^3*/
}
if (C_UDMI(c1,tc1,gridid) == 2 || C_UDMI(c1,tc1,gridid) == 3)
{
F_AREA(A,f,ft);
area = NV_MAG(A);
thrombus
=
thrombus
+
C_UDMI(c1,tc1,Xact)*kt*C_YI(c,t,0)* 1056*area/C_VOLUME(c,t); /*kg/m^3 */
}
}
if(THREAD_ID(ft)==wall1_ID || THREAD_ID(ft)==wall2_ID)
{
F_AREA(A,f,ft);
area = NV_MAG(A);
thrombus
=
thrombus
+
C_UDMI(c,t,Ma)/minf*kt*F_YI(f,ft, 1 )* 1056*area/C_VOLUME(c,t); /* kg/m^3 */
}
}
}
/* end face looop*/
source = -C_UDMI(c,t,pltact) - thrombus; /* kg/m^3*/
C_UDMI(c,t,delthu) = thrombus*0.00472/0.8;
/*retums % thrombus, assuming 20%
void volume*/
/* .0047 comes from vol/mass of platelet: 10.2 fL and 2.12 pg*/
}
if (C_UDMI(c,t,gridid)==2 || C_UDMI(c,t,gridid)==3)
source = 0.;
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if (C_UDMI(c,t,gridid)==4)
{
area = 0.;
thrombus = 0.;
c_face_loop(c,t,n)
{
ft=C_FACE_THREAD(c,t,n);
f = C_FACE(c,t,n);
c0 = F_C0(f,ft);
tc0 = THREAD_T0(ft);
c1 = F_C1(f,ft);
tc1 = THREAD_T1(ft);
if (PRINCIPAL_FACE_P(f,ft) && THREAD_ID(ft) == interior_ID)
{
if (C_UDMI(c0,tc0,gridid) == 2 || C_UDMI(c0,tc0,gridid) == 3)
{
F_AREA(A,f,ft);
area = area + NV_MAG(A);
thrombus
=
thrombus
+
C_UDMI(c0,tc0,Xact)*kt*C_YI(c,t,0)* 1056*area/C_VOLUME(c,t);
/* kg/m^3*/
}
if (C_UDMI(c1,tc1,gridid) == 2 || C_UDMI(c1,tc1,gridid) == 3)
{
F_AREA(A,f,ft);
area = area + NV_MAG(A);
thrombus
=
thrombus
+
C_UDMI(c1,tc1,Xact)*kt*C_YI(c,t,0)*1056*area/C_VOLUME(c,t); /* kg/m^3 */
}
}
}
source = -C_UDMI(c,t,pltact) - thrombus; /* kg/m^3 */
C_UDMI(c,t,delthu) = thrombus *0.00472/0.8; /*returns % thrombus,
assuming
20% void volume, see above*/
}
dS [eqn] = 0.0;
return source;
}

/* Source Term for Activated Platelets */
DEFINE_SOURCE(ap_source,c,t,dS,eqn)
{
real source,thrombus,area,A[ND_ND];
face_t f;
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cell_t c1, c0;
int n;
Thread *ft, *tc1, *tc0;
/* calculate source term for each cell

*/

if (C_UDMI(c,t,gridid)==0)
source = C_UDMI(c,t,pltact);
if(C_UDMI(c,t,gridid)==1 || C_UDMI(c,t,gridid)==5)
{
/*initialize so grid cells with two wall sides can be correctly counted*/
area = 0.;
thrombus = 0.;
c_face_loop(c,t,n)
{
ft=C_FACE_THREAD(c,t,n);
f=C_FACE(c,t,n);
c0 = F_C0(f,ft);
tc0 = THREAD_T0(ft);
c1 = F_C1(f,ft);
tc1 = THREAD_T1(ft);
if (PRINCIPAL_FACE_P(f,ft))
{
if(THREAD_ID(ft)==interior_ID)
{
if (C_UDMI(c0,tc0,gridid) == 2 || C_UDMI(c0,tc0,gridid) == 3)
{
F_AREA(A,f,ft);
area = NV_MAG(A);

thrombus
=
thrombus
+
C_UDMI(c0,tc0,Xact)*kt*C_YI(c,t,1)*1056*area/C_VOLUME(c,t);
/*kg/mA3 */
}
if (C_UDMI(c1,tc1,gridid) == 2 || C_UDMI(c1,tc1,gridid) == 3)
{
F_AREA(A,f,ft);
area = NV_MAG(A);
thrombus
=
thrombus
+
C_UDMI(c1,tc1,Xact)*kt*C_YI(c,t, 1 )* 1056*area/C_VOLUME(c,t); /*kg/mA3 */
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}
}
if(THREAD_ID(ft)==wall1_ID || THREAD_ID(ft)==wall2_ID)
{
F_AREA(A,f,ft);
area = NV_MAG(A);
thrombus
=
thrombus
+C_UDMI(c,t,Ma)/minf*kt*F_YI(f,ft,1)*1056*area/C_VOLUME(c,t); /* kg/m^3*/
}
}
}
/* end face looop*/
source = C_UDMI(c,t,pltact) - thrombus; /* kg/m^3*/
C_UDMI(c,t,delth) = thrombus*0.00472/0.8;
/*returns % thrombus, assuming
20% void volume*/
/* .0047 comes from vol/mass of platelet: 10.2 fL and 2.12 pg*/
}
if (C_UDMI(c,t,gridid)==2 || C_UDMI(c,t,gridid)==3)
{
C_UDMI(c,t,delth) = 0.;
source = 0.;
}
if (C_UDMI(c,t,gridid)==4)
{
area=0.;
thrombus = 0.;
c_face_loop(c,t,n)
{
ft=C_FACE_THREAD(c,t,n);
f = C_FACE(c,t,n);
c0 = F_C0(f,ft);
tc0 = THREAD_T0(ft);
c1 =F_C1(f,ft);
tc1 = THREAD_T1(ft);
if (PRINCIPAL_FACE_P(f,ft) && THREAD_ID(ft) == interior_ID)
{
if (C_UDMI(c0,tc0,gridid) == 2 || C_UDMI(c0,tc0,gridid) == 3)
{
F_AREA(A,f,ft);
area = area + NV_MAG(A);
thrombus
=
thrombus
C_UDMI(c0,tc0,Xact)*kt*C_YI(c,t,1)*1056*area/C_VOLUME(c,t); /* kg/m^3*/
}
if (C_UDMI(c1,tc1,gridid) == 2 || C_UDMI(c1,tc1,gridid) == 3)
{
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F_AREA(A,f,ft);
area = area + NV_MAG(A);
thrombus = thrombus + C_UDMI(c1,tc1,Xact)*kt*C_YI(c,t,1)*
1056*area/C_VOLUME(c,t); /*kg/m^3 */
}
}
}
source = C_UDMI(c,t,pltact) - thrombus;
C_UDMI(c,t,delth) = thrombus*0.00472/0.8;
}
dS[eqn] = 0.0;
return source;
}

/* Source Term for Adenosine DiPhosphate (ADP) */
DEFINE_SOURCE(adp_source,c,t,dS,eqn)
{
real source;
source = .0046*C_UDMI(c,t,pltact);
dS [eqn] = 0.0;
return source;
}

/* Source Term for Thromboxane A2 (TxA2) */
DEFINE_SOURCE(txa2_source,c,t,dS,eqn)
{
real source;
if (C_UDMI(c,t,gridid)==0 || C_UDMI(c,t,gridid)==4
C_UDMI(c,t,gridid)==5)
source = 0.164*C_YI(c,t,1)-17.002*C_YI(c,t,3);
if (C_UDMI(c,t,gridid)==2 || C_UDMI(c,t,gridid)==3)
source = 0.15;
dS[eqn] = 0.0;
return source;
}

/* Source Term for Prothrombin (pT) */

DEFINE_SOURCE(pt_source,c,t,dS,eqn)
{
real source;
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||

C_UDMI(c,t,gridid)==1

||

if (C_UDMI(c,t,gridid)==0 || C_UDMI(c,t,gridid)==1 || C_UDMI(c,t,gridid)==4)
source = -4.792e9*C_YI(c,t,4)*(3.69e-6*C_YI(c,t,1)+6.5e-7*C_YI(c,t,0));
if (C_UDMI(c,t,gridid)==2 || C_UDMI(c,t,gridid)==3)
source = -1.765e4*C_YI(c,t,4)*C_UDMI(c,t,Xact);
dS [eqn] = 0.0;
return source;
}

/* Source Term for Thrombin (th) */
DEFINE_SOURCE(thrombin_source,c,t,dS,eqn)
{
real source,generation,loss;
if (C_UDMI(c,t,gridid)==0 || C_UDMI(c,t,gridid)==4 || C_UDMI(c,t,gridid)==1)
{
generation = 4.792e9*C_YI(c,t,4)*(3.69e-6*C_YI(c,t,1) + 6.5e-7 * C_YI(c,t,0)) *0.508;
loss = 0.047*C_YI(c,t,6)/(3.5e-9+2.885e-3*C_YI(c,t,5) + 5.96e-4*C_YI(c,t,6) +
491.423*C_YI(c,t,6)*C_YI(c,t,5))*C_YI(c,t,5)* 1056.;
source = generation - loss;
}
if (C_UDMI(c,t,gridid)==2 || C_UDMI(c,t,gridid)==3)
{
generation = 8.973e3 *C_YI(c,t,4)*C_UDMI(c,t,Xact);
loss = 0.047*C_YI(c,t,6)/(3.5e-9+2.885e-3*C_YI(c,t,5) + 5.96e-4*C_YI(c,t,6) + 491.423
*C_YI(c,t,6)*C_YI(c,t,5))*C_YI(c,t,5) * 1056.;

source = generation - loss;
}
dS[eqn] = 0.0;
return source;
}

/* Source Term for antithrombin HI (at) */
DEFINE_SOURCE(at_source,c,t,dS,eqn)
{
real source;
source = -84.077*C_YI(c,t,6)/(3.5e-9+2.885e-3*C_YI(c,t,5)+5.96e-4*C_YI(c,t,6)+491.423
*C_YI(c,t,6)*C_YI(c,t,5)) *C_YI(c,t,5);
dS [eqn] = 0.0;
return source;
}

XXV

/* Diffusivity Definition */
DEFINE_DIFFUSIVITY(Diffusivity, c, t, i)
{
real source;
if (i==0)
{
source = 6.0e-14*C_UDMI(c,t,gama)+1.58e-13;
}
if (i==1)
{
source = 6.0e-14*C_UDMI(c,t,gama)+1.58e-13;
}
if (i==2)
{
source = 2.57e-10;
}
if (i==3)
{
source = 2.14e-10;
}
if (i==4)
{
source = 6.0e-14*C_UDMI(c,t,gama)+3.32e-11;
}
if (i==5)
{
source = 6.0e-14*C_UDMI(c,t,gama)+4.16e-11;
}
if (i==6)
{
source = 6.0e-14*C_UDMI(c,t,gama)+3.49e-11;
}
/*if (i==7)
{
source = 6.0e-14*C_UDMI(c,t,gama)+3.49e-11;
}
/*Message("i%d", i);
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Message("mass_diff%e", source);*/
return source;
}
/*Source Terms to Generate Initial Concentrations of Species*/
DEFINE_SOURCE(rp_init,c,t,dS,eqn)
{
real source;
real curr_int = RP_Get_Real("flow-time");
source = 0;
if (curr_int==delt_int)
{
source = 0.0006;
dS [eqn]=0.0;
}
return source;
}
DEFINE_SOURCE(ap_init,c,t,dS,eqn)
{
real source;
real curr_int = RP_Get_Real("flow-time");
source = 0;
if (curr_int==delt_int)
{
source = 0.000006;
dS [eqn]=0.0;
}
return source;
}
DEFINE_SOURCE(pt_init,c,t,dS,eqn)
{
real source;
real curr_int = RP_Get_Real("flow-time");
source = 0;
if (curr_int==delt_int)
{
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source = 0.000075;
dS [eqn]=0.0;
}
return source;
}
DEFINE_SOURCE(at_init,c,t,dS,eqn)
{
real source;
real curr_int = RP_Get_Real("flow-time");
source = 0;
if (curr_int==delt_int)
{
source = 0.000167;
dS [eqn]=0.0;
}
return source;
}
/* Surface Reaction Rates */
DEFINE_SR_RATE(Surface_Reactions, f, t, r, mw, yi, rr)
{
Thread *t0=t->t0;
cell_t c0=F_C0(f,t);
/*Reaction 1: Unactivated platelet adhesion
rp --> dp
rate = Sa*kps*Xrp*rho/mwplt
to get plt/m^2: kps*Xrp*rho/massplt (hence 4.774e17)*/
if (STREQ(r->name, "reaction-1"))
{
C_UDMI(c0,t0,rpadh) = C_UDMI(c0,t0,Sa)*krs*yi[0]*4.774e17; /* plt/m^2-s*/

/*Memb = M*(1-exp(-.000309*gama))/temb, units in platelet/m^2
in the exponent, 0.0095*0.00325 (visc)/0.1(converson to dynes/cm2) */
C_UDMI(c0,t0,upemb)=
C_UDMI(c0,t0,M)*(1.-C_UDMI(c0,t0,Xact))*(1.exp(.000309*C_UDMI(c0,t0,gama)))/temb; /* returns plt/m^2-s */
*rr =C_UDMI(c0,t0,Sa)*krs*yi[0]* 1056./mw[0] - C_UDMI(c0,t0,upemb)/6.023e26; /*
returns rate in kmoles/m^2-s*/
}
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/*Reaction 2: Activated platelet adhesion
ap --> dp rate = Sa*kas*Xap*rho/mwplt */
if (STREQ(r->name, "reaction-2"))
{
*rr = C_UDMI(c0,t0,Sa)*kas*yi[1]*1056./mw[1]; /* returns rate in kmoles/m^2-s */
C_UDMI(c0,t0,apadh) = C_UDMI(c0,t0,Sa)*kas*yi[1]*4.774e17; /* plt/m^2-s*/

}

/*Reaction 3: Release of TxA2 from deposited platelets dp --> dp + txa2 rate = M*St =
M(plt/m^2)*(9.5e-21mo1Txa2/plt-s) leave the stoichiometry at 0 for dp, 1 for txa2 */
if (STREQ(r->name, "reaction-3"))
{
*rr = C_UDMI(c0,t0,M)*C_UDMI(c0,t0,Xact)*9.5e-24; /*
returns
rate
in
kmoles/m^2-s */
}

/*Reaction 4: Release of Thrombin from deposited platelets
dp + pT --> dp + th
rate = M*fi*pT = M(plt/m^2)*3.55e-14(kg-blood/plt-s)*Xi[pT]/mwpT stoichiometry for the
reaction: 1 for pT and th; 0 for dp */
if (STREQ(r->name, "reaction-4"))
{
*rr = C_UDMI(c0,t0,M)*C_UDMI(c0,t0,Xact)*3.55e-14*yi[4]/mw[4];
/*returns rate in kmoles/m^2-s */
}
}
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Appendix D Standard Operating Procedure for Blood
Collection
Scope
To describe the procedure for collection and storage of whole blood. This
procedure is designed to maintain the physiological properties of blood. The
blood can then be used in experiments of hemolysis, coagulation, or other
properties of blood. This procedure is meant to be scaled depending on quantity
of blood required.
Requirements
Materials:
1.
2.
3.
4.
5.
6.

Large container (1000ml beaker – 6qt cooking pot)
Ice chest
Ice
Storage container (PETG bottles – PVC blood bag)
__ ft^2 of PVC sheet
Heparin (or other anticoagulant)

Equipment and Instruments:
Scale
Heat sealer
Procedures
Collection of Blood from Slaughter House:
1. Determine amount of blood required.
2. Determine the large collection container. The container should have a volume 3
times the amount of blood required, and should also be round. Because the
blood will never come in contact with this container, material is not a
consideration.
3. Cut two pieces of PVC film in the same shape. The shape should be twice as tall
as the collection container and be wider than the diameter of the container.
4. Place the PVC shapes on top of each other. Using the heat sealer, create a seal
about ½” thick on three sides of the PVC. This makes a pouch with one open
end. This open end is where the blood will come into the pouch.
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5. Place the PVC pouch inside the large collection container and fold the top of the
pouch over the side of the collection container. Secure with clips or rubber bands
of necessary.
6. Measure the amount of blood required and mark it on the PVC pouch.
7. Measure the amount of heparin needed and place in the PVC pouch. The
recommended amount of heparin is 1.5U/ml. This can be changed based on
individual needs. The activity of a particular heparin should be given on the bottle
in U/mg. Other anticoagulants can be used in a similar fashion but with different
quantities.
8. When using a commercial butcher, have the large collection container with the
PVC pouch inside and the pre-measured anticoagulant inside the PVC pouch all
prepared. Hand this to the butcher and they will hand it back to you filled with
blood.
9. If a large quantity of blood is being collected (>1L) the blood should be gently
mixed to ensure the anticoagulant is evenly distributed.
10. Remove the PVC pouch from the large container. Pour the blood into storage
container such as PETG bottles or PVC blood bag. Try to avoid foaming the
blood while pouring. While the PVC pouch can be used to store the blood, it is
recommended that a different bag be used for storage because of sanitation
issues.
11. Place the storage container that is now containing blood on ice for transport.
12. Label storage container as “Bovine Whole Blood” Also label with the date of
collection and date to be discarded. The date to be discarded can be up to 60
days after date of collection. After 60 days, the blood has lost all physiological
properties.
13. The blood can now either be used or stored between 2-4 C for a few days.
Precise time when blood is no longer good is dependent of the experiment being
preformed on the blood.
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Appendix E Standard Operating Procedure (SOP) for
Concentric Cylinders Test Stand
This devices is intended to expose a fluid to a controlled shear rate. This is
done by controlling both the gap between the cylinders and the rate at which
the outer cylinder rotates. The speed at which the outer cylinder rotates is
controlled by a DC motor and power supply. Please follow the startup
procedure below whenever using this device.
Equipment and Instrumentation
1) Concentric Cylinder test stand including DC motor
2) power supply
3) frequency counter
Procedure
1) Center the inner cylinder in the outer cylinder
a) Make sure the pillow blocks of the outer cylinder are tight.
b) Loosen all the fasteners for the inner cylinder. This includes: the collar
around the 1.5 stainless steal, and both of the fasterners on the 90
degree, 0.5 in post holder.
c) Place the brass sleave in the outer cylinder, then place the inner
cylinder in the brass sleave. The brass sleave acts as a physical
centering device for the cylinders.
d) Tighten the fasteners of the inner cylinder being careful to maintain
the best possible alignment.
e) Once all three fasteners are tightened, loosen the fastner holding the
post the is directly connected to the inner cylinder. Pull the post
directly up, removing the inner cylinder from the outer cylinder and
the brass sleave. The post should raise with minimal resistance. If you
feel resistance, that means the cylinders are misaligned and you
should begin from step (a) again.
f) Remove the brass sleave.
g) Replace the inner cylinder into the outer cylinder. The two cylinders
should be concentric now.
2) Place the fluid in the test section.
3) Expose the fluid to shear stress.
a) Turn on the power supply. It is recommened that the power supply by
turned to 0 V when you turn it on.
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b) Turn up the voltage until the desired RPM is reached.
i) The Counter reports revolutions/sec, so unit convertions may be
neccesary.
c) If the cylinders are misaligned, fluid will spray or foam in the test
section if high shears are induced. It is recommened that you cover
the device while in operation.
4) The fluid and cylinders can now be examined depending on the current
experimental needs.
5) The cylinders should be thoroghly washed before the next experiment.
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Appendix F Drawing Package for Concentric Cylinder
Test Stand
Part #
Part name
Drawing name Vendor
7173628 .75x1.625 in deep groove bearing
bearings
MSC
p6
6" mounting post
thor_p6
thor labs
p14
14" mounting post
thor_p14
thor labs
pb1
mounting post base
thor_pb1
thor labs
c1525
post clamp and 4.5x4.5 in mounting surface
thor_c1525
thor labs
c1501
mounting post clamp
thor_c1501
thor labs
ra90
right angle post clamp
thor_ra90
thor labs
c1500
compact p-series post clamp
thor_c1500
thor labs
c1498
slip on post clamp
thor_c1498
thor labs
tr2
1/2" post
thor_tr2
thor labs
1LWK8
DC Motor,12v,1/35 HP,2350 RPM,3.8 A,TENV
Gainger
Rig1
Bearing block
bearingblock in-house
Rig2
Base Plate
base plate
in-house
Rig3
Inner cylinder
inner cylinder in-house
Rig4
Outer Cylinder
outer cylinder in-house
Table E.1: List of parts in the concentric cylinder test stand. Part# references the vendor
part # and corresponds to the annotations in the complete assembly drawing. Drawing
name in the name of the file found on the media.

XXXIV

XXXV

XXXVI

XXXVII

XXXVIII

XXXIX

XL

XLI

XLII

XLIII

XLIV

XLV

XLVI

XLVII

XLVIII

XLIX

Appendix G Standard Operating Procedure for PT and
APTT tests from Stiene-Martin, Clinical Hematology,
pg. 638-639

L

LI

LII

